1. Home
  2. TCI vs GOSS Comparison

TCI vs GOSS Comparison

Compare TCI & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • GOSS
  • Stock Information
  • Founded
  • TCI 1983
  • GOSS 2015
  • Country
  • TCI United States
  • GOSS United States
  • Employees
  • TCI N/A
  • GOSS N/A
  • Industry
  • TCI Real Estate
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCI Finance
  • GOSS Health Care
  • Exchange
  • TCI Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • TCI 357.8M
  • GOSS 347.8M
  • IPO Year
  • TCI N/A
  • GOSS 2019
  • Fundamental
  • Price
  • TCI $45.60
  • GOSS $2.47
  • Analyst Decision
  • TCI
  • GOSS Strong Buy
  • Analyst Count
  • TCI 0
  • GOSS 4
  • Target Price
  • TCI N/A
  • GOSS $8.50
  • AVG Volume (30 Days)
  • TCI 1.8K
  • GOSS 3.1M
  • Earning Date
  • TCI 08-07-2025
  • GOSS 08-05-2025
  • Dividend Yield
  • TCI N/A
  • GOSS N/A
  • EPS Growth
  • TCI 11.20
  • GOSS N/A
  • EPS
  • TCI 0.76
  • GOSS N/A
  • Revenue
  • TCI $47,730,000.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • TCI N/A
  • GOSS N/A
  • Revenue Next Year
  • TCI N/A
  • GOSS $30.65
  • P/E Ratio
  • TCI $61.66
  • GOSS N/A
  • Revenue Growth
  • TCI N/A
  • GOSS N/A
  • 52 Week Low
  • TCI $25.50
  • GOSS $0.66
  • 52 Week High
  • TCI $48.00
  • GOSS $2.65
  • Technical
  • Relative Strength Index (RSI)
  • TCI 56.33
  • GOSS 68.08
  • Support Level
  • TCI $46.00
  • GOSS $2.38
  • Resistance Level
  • TCI $48.00
  • GOSS $2.65
  • Average True Range (ATR)
  • TCI 0.80
  • GOSS 0.15
  • MACD
  • TCI 0.05
  • GOSS 0.03
  • Stochastic Oscillator
  • TCI 67.90
  • GOSS 76.67

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: